Stryker (SYK) Insider Sale: Viju Menon Sells 500 Shares at $390.61
Insider transaction summary: Stryker Corporation director and Group President Viju Menon reported a sale of 500 shares of Stryker common stock on 08/25/2025 at a reported price of $390.61 per share.
Rhea-AI Filing Summary
Insider transaction summary: Stryker Corporation director and Group President Viju Menon reported a sale of 500 shares of Stryker common stock on 08/25/2025 at a reported price of $390.61 per share. After the sale, Mr. Menon beneficially owns 12,511 shares directly and 197 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 08/27/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale disclosed; ownership remains concentrated with a modest reduction in direct holdings.
This Form 4 records a straightforward sale by an executive-level insider. The sale of 500 shares at $390.61 reduced direct beneficial ownership to 12,511 shares while 197 shares remain held indirectly via a 401(k). There is no accompanying derivative activity or indication of a Rule 10b5-1 plan in the filing. As presented, the disclosure is routine and compliant, providing transparency about the insider's post-transaction holdings.
TL;DR: Single small disposal reported; transaction size appears immaterial to company capitalization.
The filing documents a single disposition of 500 common shares by a reporting officer. The transaction price is stated as $390.61 per share and the filing shows remaining direct and indirect holdings. No options, grants, or derivative positions are disclosed. From a market-impact perspective, the sale is small relative to typical public-company float and contains no additional contextual details.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 500 | $390.61 | $195K |
| holding | Common Stock | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Viju Menon report on the Form 4 for SYK?
Was any derivative or option activity disclosed in this Form 4 for SYK?
Who signed the Form 4 and when was it signed?
Does the Form 4 indicate whether the sale was made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.